Health Italia S.p.A. (BIT:HI)
Italy · Delayed Price · Currency is EUR 297.00
0.00 (0.00%)
At close: Jan 21, 2026
Health Italia Revenue
Health Italia had revenue of 20.76M EUR in the half year ending June 30, 2025, with 15.02% growth. This brings the company's revenue in the last twelve months to 37.83M, up 0.94% year-over-year. In the year 2024, Health Italia had annual revenue of 36.59M with 1.60% growth.
Revenue (ttm)
37.83M
Revenue Growth
+0.94%
P/S Ratio
1.47
Revenue / Employee
343.91K
Employees
106
Market Cap
55.53M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 36.59M | 574.87K | 1.60% |
| Dec 31, 2023 | 36.01M | -6.50M | -15.29% |
| Dec 31, 2022 | 42.51M | 2.00M | 4.94% |
| Dec 31, 2021 | 40.51M | 7.66M | 23.33% |
| Dec 31, 2020 | 32.84M | 1.05M | 3.31% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 2.55B |
| Amplifon | 2.41B |
| DiaSorin | 1.21B |
| EL.En. | 580.41M |
| GPI S.p.A. | 531.42M |
| Svas Biosana | 134.95M |
| Talea Group | 132.17M |
| Farmacosmo | 59.23M |